These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14678636)

  • 1. The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms.
    Olivier M; Badaró R; Medrano FJ; Moreno J
    Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():79-98. PubMed ID: 14678636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunology of Leishmania/HIV co-infection.
    Okwor I; Uzonna JE
    Immunol Res; 2013 May; 56(1):163-71. PubMed ID: 23504228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunopathologic changes in HIV-Leishmania co-infection].
    Da-Cruz AM; Rodrigues AC; Mattos M; Oliveira-Neto MP; Sabbaga-Amato V; Posada MP; Lindoso JA; Goto H
    Rev Soc Bras Med Trop; 2006; 39 Suppl 3():75-9. PubMed ID: 17605214
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of interaction between protozoan parasites and HIV.
    Andreani G; Lodge R; Richard D; Tremblay MJ
    Curr Opin HIV AIDS; 2012 May; 7(3):276-82. PubMed ID: 22418447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania-HIV interaction: immunopathogenic mechanisms.
    Wolday D; Berhe N; Akuffo H; Britton S
    Parasitol Today; 1999 May; 15(5):182-7. PubMed ID: 10322351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biological diagnosis of leishmaniasis in HIV-infected patients.
    Deniau M; Cañavate C; Faraut-Gambarelli F; Marty P
    Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():115-33. PubMed ID: 14678639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
    Ali A
    Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunobiology of leishmaniasis.
    Sharma U; Singh S
    Indian J Exp Biol; 2009 Jun; 47(6):412-23. PubMed ID: 19634705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine networks with infection: mycobacterial infections, leishmaniasis, human immunodeficiency virus infection, and sepsis.
    DiPiro JT
    Pharmacotherapy; 1997; 17(2):205-23. PubMed ID: 9085311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR4-mediated activation of MyD88 signaling induces protective immune response and IL-10 down-regulation in Leishmania donovani infection.
    Paul J; Naskar K; Chowdhury S; Alam MN; Chakraborti T; De T
    Indian J Biochem Biophys; 2014 Dec; 51(6):531-41. PubMed ID: 25823227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological findings in HIV-Leishmania coinfection.
    Preiser W; Cacopardo B; Nigro L; Braner J; Nunnari A; Doerr HW; Weber B
    Intervirology; 1996; 39(4):285-8. PubMed ID: 9078471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania/HIV co-infection in Brazil: an appraisal.
    Rabello A; Orsini M; Disch J
    Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():17-28. PubMed ID: 14678630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania/HIV co-infections: epidemiology in Europe.
    Desjeux P; Alvar J
    Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():3-15. PubMed ID: 14678629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T; Anam K; Ali N
    Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients.
    García-García JA; Martín-Sánchez J; Gállego M; Rivero-Román A; Camacho A; Riera C; Morillas-Márquez F; Vergara S; Macías J; Pineda JA
    J Clin Microbiol; 2006 Dec; 44(12):4455-8. PubMed ID: 17050814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulator and effector functions of T-cell subsets in human Leishmania infections.
    Kemp M
    APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V
    Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of chemokines in Leishmania infection.
    Roychoudhury K; Roy S
    Curr Mol Med; 2004 Sep; 4(6):691-6. PubMed ID: 15357217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-producing T cell subsets in human leishmaniasis.
    Kemp K
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):173-6. PubMed ID: 10912621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.